Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A preliminary report on ABO incompatible bone marrow transplant.

P Tan1, Y W Ong, S L Tien

  • 1Department of Haematology, Singapore General Hospital.

Annals of the Academy of Medicine, Singapore
|July 1, 1991
PubMed
Summary

Allogeneic bone marrow transplants (BMT) with ABO blood group incompatibility showed similar engraftment and graft-versus-host disease (GVHD) rates. However, major ABO incompatibility significantly delayed red blood cell development and recovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perforated Rectal Cancer Presenting With Symptoms of Sciatic Nerve Compression: A Case Report.

Case reports in surgery·2025
Same author

[The roles of m6A-modified regulatory factors in the development of malignant tumors].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025
Same author

Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis.

Human reproduction (Oxford, England)·2024
Same author

Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes.

ESMO open·2024
Same author

Cardiac Time Intervals Under Motion Using Bimodal Chest E-Tattoos and Multistage Processing.

IEEE transactions on bio-medical engineering·2024
Same author

Microstructural, Micromechanical Atlas of the Temporomandibular Joint Disc.

Journal of dental research·2024

Area of Science:

  • Hematology
  • Transplantation Immunology

Background:

  • Allogeneic bone marrow transplantation (BMT) is a critical treatment for hematologic malignancies.
  • ABO blood group compatibility is a key consideration in donor-recipient matching for BMT.
  • Understanding the impact of ABO incompatibility is crucial for optimizing BMT outcomes.

Purpose of the Study:

  • To evaluate the outcomes of allogeneic BMT in patients with major and minor ABO blood group incompatibility.
  • To compare engraftment, recovery kinetics, and graft-versus-host disease (GVHD) incidence between ABO-incompatible and ABO-compatible BMT.

Main Methods:

  • Retrospective analysis of five major and six minor ABO-incompatible allogeneic BMT cases.
  • Comparison of engraftment time, peripheral blood cell recovery (leukocytes, granulocytes, platelets), and GVHD incidence.

Related Experiment Videos

  • Assessment of erythroid development and reticulocytosis.

    • Main Results:

    • Engraftment, leukocyte, granulocyte, and platelet recovery rates were similar in ABO-incompatible and compatible BMT.
    • Graft-versus-host disease (GVHD) incidence was comparable between ABO-incompatible and compatible BMT groups.
    • Significant delays in erythroid development and reticulocytosis were observed in major ABO-incompatible BMT recipients.

    Conclusions:

    • Allogeneic BMT can be performed successfully despite ABO blood group incompatibility, with similar engraftment and GVHD rates.
    • Major ABO incompatibility poses a specific challenge, leading to delayed erythroid recovery.
    • Further strategies may be needed to mitigate delayed erythroid development in major ABO-incompatible BMT.